Literature DB >> 1906189

Pancreatic enhancement after low-dose infusion of Mn-DPDP.

H B Gehl1, D Vorwerk, K C Klose, R W Günther.   

Abstract

Enhancement of the pancreas was demonstrated after low-dose (10 mumol/kg) infusion of a new contrast agent for magnetic resonance (MR) imaging, manganese dipyridoxal-diphosphate (Mn-DPDP). To the authors' knowledge, this has not been described previously. The enhancement reached a maximum of 98% +/- 13% (standard deviation) during a long period (greater than 6 hours). Mn-DPDP seems to have potential as a selective contrast agent in MR imaging of the pancreas.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1906189     DOI： 10.1148/radiology.180.2.1906189

Source DB:  PubMed          Journal:  Radiology        ISSN： 0033-8419            Impact factor:   11.105


  6 in total

Review 1.  Pancreatic adenocarcinoma.

Authors:  Wolfgang Schima; Ahmed Ba-Ssalamah; Claus Kölblinger; Christiane Kulinna-Cosentini; Andreas Puespoek; Peter Götzinger
Journal:  Eur Radiol       Date:  2006-10-05       Impact factor: 5.315

2.  Mangafodipir trisodium-enhanced magnetic resonance imaging for evaluation of pancreatic mass and mass-like lesions.

Authors:  Gul Eser; Aydin Karabacakoglu; Serdar Karakose; Cengiz Eser; Ertugrul Kayacetin
Journal:  World J Gastroenterol       Date:  2006-03-14       Impact factor: 5.742

3.  Mangafodipir trisodium-enhanced MR imaging of pancreatic disease.

Authors:  Piero Boraschi; Francescamaria Donati; Roberto Gigoni; Davide Caramella; Ugo Boggi; Fabio Falaschi; Carlo Bartolozzi
Journal:  Eur Radiol       Date:  2006-01-19       Impact factor: 5.315

Review 4.  [Pancreas. Part II: Tumors].

Authors:  W Schima; A Ba-Ssalamah; C Plank; C Kulinna-Cosentini; R Prokesch; B Tribl; T Sautner; B Niederle
Journal:  Radiologe       Date:  2006-05       Impact factor: 0.635

5.  Enhancement of the normal pancreas: comparison of manganese-DPDP and gadolinium chelate.

Authors:  U Kettritz; D M Warshauer; E D Brown; J F Schlund; L B Eisenberg; R C Semelka
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

Review 6.  Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications.

Authors:  Peter Reimer; Günter Schneider; Wolfgang Schima
Journal:  Eur Radiol       Date:  2004-02-25       Impact factor: 5.315
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.